We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $116B
1-Year Est. Return 61.47%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$50B
AUM Growth
-$1.69B
Cap. Flow
-$1.94B
Cap. Flow %
-3.88%
Top 10 Hldgs %
21.09%
Holding
2,870
New
69
Increased
959
Reduced
1,347
Closed
66

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$632M
2
NVDA icon
NVIDIA
NVDA
+$337M
3
EZU icon
iShare MSCI Eurozone ETF
EZU
+$273M
4
LRCX icon
Lam Research
LRCX
+$193M
5
CSX icon
CSX Corp
CSX
+$188M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 13.43%
3 Consumer Discretionary 13%
4 Financials 12.6%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
2601
Cue Biopharma
CUE
$131M
$180K ﹤0.01%
411
CMRX
2602
DELISTED
Chimerix, Inc.
CMRX
$180K ﹤0.01%
29,029
KBAL
2603
DELISTED
Kimball International
KBAL
$179K ﹤0.01%
15,964
SGFY
2604
DELISTED
Signify Health, Inc.
SGFY
$179K ﹤0.01%
+10,006
New +$257K
VKTX icon
2605
Viking Therapeutics
VKTX
$3.84B
$178K ﹤0.01%
28,353
VLDR
2606
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$178K ﹤0.01%
30,057
+2,761
+10% +$20.8K
TRUE
2607
DELISTED
TrueCar
TRUE
$177K ﹤0.01%
42,478
+165
+0.4% +$766
NPTN
2608
DELISTED
NEOPHOTONICS CORP
NPTN
$177K ﹤0.01%
20,274
DX
2609
Dynex Capital
DX
$3.23B
$176K ﹤0.01%
+10,196
New +$180K
GRTS
2610
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$176K ﹤0.01%
16,274
OSBC icon
2611
Old Second Bancorp
OSBC
$1.31B
$175K ﹤0.01%
13,429
KPTI icon
2612
Karyopharm Therapeutics
KPTI
$45.1M
$172K ﹤0.01%
1,975
+12
+0.6% +$1.25K
ASXC
2613
DELISTED
Asensus Surgical, Inc.
ASXC
$172K ﹤0.01%
92,734
PCT icon
2614
PureCycle Technologies
PCT
$1.41B
$171K ﹤0.01%
12,872
ALDX icon
2615
Aldeyra Therapeutics
ALDX
$86.9M
$168K ﹤0.01%
19,097
EZPW icon
2616
Ezcorp Inc
EZPW
$1.76B
$168K ﹤0.01%
22,146
RMNI icon
2617
Rimini Street
RMNI
$470M
$168K ﹤0.01%
17,452
AKTS
2618
DELISTED
Akoustis Technologies Inc
AKTS
$166K ﹤0.01%
17,102
MRNS
2619
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$166K ﹤0.01%
14,615
ZIXI
2620
DELISTED
Zix Corporation
ZIXI
$166K ﹤0.01%
23,489
+1,322
+6% +$9.54K
DAKT icon
2621
Daktronics
DAKT
$988M
$165K ﹤0.01%
30,419
+1,357
+5% +$8.06K
GERN icon
2622
Geron
GERN
$982M
$164K ﹤0.01%
119,573
SFT
2623
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$164K ﹤0.01%
2,363
GLRE icon
2624
Greenlight Captial
GLRE
$512M
$163K ﹤0.01%
22,012
+660
+3% +$5.51K
ALHC icon
2625
Alignment Healthcare
ALHC
$2.79B
$162K ﹤0.01%
10,111

Similar funds

VOYA Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, VOYA Investment Management held 2,870 positions worth $50B, down 3.3% from $51.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

VOYA Investment Management withdrew a net $1.94B in Q3 2021, closing 66 positions and reducing 1,347 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, VOYA Investment Management opened a new position in GXO Logistics worth $17.1M.

  • VOYA Investment Management's largest Q3 2021 buy was GXO Logistics: 217,480 shares worth $17.1M.
  • VOYA Investment Management added most to Alphabet (Google) Class A in Q3 2021, an estimated $254M increase.
  • VOYA Investment Management's biggest Q3 2021 reduction was Amazon, cutting an estimated $632M.
  • VOYA Investment Management fully exited iShare MSCI Eurozone ETF in Q3 2021, selling an estimated $273M.
  • VOYA Investment Management's ten largest holdings make up 21% of its $50B portfolio in Q3 2021.
  • VOYA Investment Management opened 69 new positions and closed 66 in Q3 2021.
  • VOYA Investment Management's portfolio value fell 3.3% quarter-over-quarter to $50B.

Based on VOYA Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.